Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Malignant Liver Tumors Who Are Unsuitable for Surgical Resection, Irreversible Electroporation (IRE) Ablation Will be Performed for Tumors Located Adjacent to Blood Vessels.

NCT07214363 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07214363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07214363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Malignant Liver Tumors Who Are Unsuitable for Surgical Resection, Irreversible Electroporation (IRE) Ablation Will be Performed for Tumors Located Adjacent to Blood Vessels.
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2023
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ablation techniques, liver cancer, radiology